dc.contributor.author | Davis, J. Delrene | eng |
dc.contributor.author | Harper, Amy | eng |
dc.date.issued | 2011 | eng |
dc.description.abstract | A six-month treatment regimen with an antifungal agent decreases the recurrence of vulvovaginal candidiasis. (Strength of Recommendation [SOR]: A, based on good-quality randomized controlled trials [RCTs].) For women in mycologic remission, a six-month treatment regimen with an antifungal agent may result in an additional five to 10 months of clinical cure. (SOR: A, based on good-quality RCTs.) Suitable therapies include oral fluconazole (Diflucan; 150 mg once per week for six months) or oral itraconazole (Sporanox; 200 mg twice per day, one day per month for six months). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/11926 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2011 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | American family physician, 83, no. 12 (June 2011): 1482-1484. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | fungal infection | eng |
dc.subject | mycologic remission | eng |
dc.subject.lcsh | Infection | eng |
dc.subject.lcsh | Mycoses | eng |
dc.title | Treatment of Recurrent Vulvovaginal Candidiasis | eng |
dc.type | Article | eng |